sglt2 inhibitor glp 1 agonist combination Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and therapy with inhibitors and finerenone: a narrative review and perspectives | Cardiovascular Diabetology Effect of combination treatment with
Description
Julius A, Hopper W
The medication worked because people maintained consistent use
Enteroendocrine L cells sense LPS after gut barrier injury to enhance GLP-1 secretion
2024;35 doi: 10.1016/j.jcte.2024.100333
Alicic RZ, Cox EJ, Neumiller JJ, Tuttle KR
While NAION can happen spontaneously in people with risk factors such as diabetes, hypertension, and sleep apnea, researchers began to wonder if GLP-1 medications might increase risk
